|
|
Volumn 7, Issue 2, 2001, Pages 51-54
|
|
Comparison of antimicrobial susceptibility test breakpoints of national societies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIKACIN;
AMOXICILLIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
CEFAZOLIN;
CEFOTAXIME;
CEFOXITIN;
CEFTAZIDIME;
CEFUROXIME;
CHLORAMPHENICOL;
CIPROFLOXACIN;
CLINDAMYCIN;
COTRIMOXAZOLE;
ERYTHROMYCIN;
FUSIDIC ACID;
GENTAMICIN;
IMIPENEM;
METICILLIN;
NITROFURANTOIN;
OXACILLIN;
PENICILLIN G;
PIPERACILLIN;
PIPERACILLIN PLUS TAZOBACTAM;
RIFAMPICIN;
TEICOPLANIN;
TETRACYCLINE;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
BACTERIAL STRAIN;
COAGULASE NEGATIVE STAPHYLOCOCCUS;
COAGULASE POSITIVE STAPHYLOCOCCUS;
CONTROLLED STUDY;
DILUTION;
ENTEROBACTERIACEAE;
ENTEROCOCCUS;
EUROPE;
GRAM POSITIVE BACTERIUM;
HAEMOPHILUS;
MEDICAL SOCIETY;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
NOTE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PSEUDOMONAS;
STREPTOCOCCUS PNEUMONIAE;
BACTERIA (MICROORGANISMS);
ENTEROBACTERIACEAE;
ENTEROCOCCUS;
HAEMOPHILUS;
POSIBACTERIA;
PSEUDOMONAS;
STAPHYLOCOCCUS;
STREPTOCOCCUS;
STREPTOCOCCUS PNEUMONIAE;
|
|
EID: 0035262118
PISSN: 1198743X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1469-0691.2001.00201.x Document Type: Article |
|
Times cited : (10)
|
|
References (10)
|
